Worse renal outcome of subclass IV-G lupus nephritis patients over IV-S

Abstract

Background

International Society of Nephrology/ Renal Pathology Society (ISN/RPS) consensus on the classification of lupus nephritis (LN) subdivided class IV into diffuse segmental (IV-S) and diffuse global (IV-G). Nephrologists and nephropathologists believe that this subclassification would be clinically relevant based on hypothetical distinct immunopathogenesis of those subclasses guiding therapy as well as judging prognosis.

Methods

All adult patients with a renal biopsy-confirmed diagnosis of LN class IV undergoing regular follow-up in the Nephrology Division between January 2004 and December 2014 were enrolled excluding those with diabetes, hepatitis B, hepatitis C, HIV as well as those with insufficient clinical and hystopathological data. Biopsies were reviewed and reclassified according to ISN/RPS 2003 classification by two experienced pathologists and were examined by light microscopy and direct immunofluorescence.

Results

On baseline subclass IV-G compared to IV-S showed higher frequency of males and histologically higher activity (7.5 ± 2.8 vs 5.1 ± 2.3, p = 0.004) and chronicity index (3.4 ± 1.6 vs 2.4 ± 1.8, p = 0.016) as well as a higher percentage of epithelial crescents (12.9 vs 5.1, p = 0.0001) and vessel abnormalities (72% vs 42%, p = 0.017). Although renal function on baseline was not different between subclasses, IV-G showed lower levels, although not significant, of estimated glomerular filtration based on CKD-EPI formula (91.0 ± 34.8 vs 64.4 ± 44.5, p = 0.059) at the end of follow-up. In addition, we observed a higher rate of patients reaching CKD-EPI under 60 mL/min/1.73 m² in subclass IV-G over IV-S on last follow-up.

Conclusion

Subclasses IV-S and IV-G patients show some clinical and pathological differences that might represent distinct stages of the same disease and they should thus be treated the same.

Keywords

Renal lupus systemic lupus erythematosus nephritis

Get full access to this article

View all access options for this article.

References

Weening

D’Agati

Schwartz

Seshan

Alpers

Appel

et al.

(International Society of Nephrology/Renal Pathology Society Working Group on the Classification of Lupus Nephritis). The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521–530.

Najafi

Korbet

Lewis

Schwartz

Reichlin

Evans

. (Lupus Nephritis Collaborative Study Group). Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 2001; 59: 2156–2163.

Mittal

Hurwitz

Rennke

Singh

. New subcategories of class IV lupus nephritis: Are there clinical, histologic, and outcome differences? Am J Kidney Dis 2004; 44: 1050–1059.

Yokoyama

Wada

Hara

Yamahana

Nakaya

Kobayashi

et al.

Kanazawa Study Group for Renal Diseases and Hypertension. The outcome and a new ISN/RPS 2003 classification of lupus nephritis [in Japanese]. Kidney Int 2004; 66: 2382–2388.

Hill

Delahousse

Nochy

et al.

Class IV-S versus class IV-G lupus nephritis: Clinical and morphologic differences suggesting different pathogenesis. Kidney Int 2005; 68: 2288–2297.

Haring

Rietveld

van den Brand

Berden

. Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes. J Am Soc Nephrol 2012; 23: 149–154.

Wilhelmus

Alpers

Cook

Ferrario

Fogo

Haas

et al.

The revisited classification of GN in SLE at 10 Years: Time to re-evaluate histopathologic lesions. J Am Soc Nephrol 2015; 26: 2938–2946.

Tan

Cohen

Fries

et al.

The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.

Buhaescu

Covic

Deray

. Treatment of proliferative lupus nephritis – a critical approach. Semin Arthritis Rheum 2007; 36: 224–237.

10.

Austin

3rd Muenz

Joyce

et al.

Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25: 689–695.

11.

Levey

Lan

Corwin

et al.

Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short term oral cyclophosphamide. Ann Intern Med 1992; 116: 114–123.

12.

Colares

Titan

Pereira

Malafonte

et al.

MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population. PLoS ONE 2014; 9(3): e87716–e87716.

13.

Markowitz

D’Agati

. Classification of lupus nephritis. Curr Opin Nephrol Hypertens 2009; 18(3): 220–225.

14.

Vandepapelière

Aydin

Cosyns

et al.

Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus nephritis inception cohort. Lupus 2014; 23: 159–165.

15.

Liu

Chen

et al.

Diffuse segmental and pure diffuse global proliferative glomerulonephritis: Different patterns of class IV lupus nephritis. Clinical Nephrology 2014; 81: 411–418.

16.

Gao

Cai

Liu

Tang

et al.

Characteristics and influence factors of pathologic transformation in the subclasses of class IV lupus nephritis. Rheumatol Int 2012; 32: 1751–1759.

17.

Tan

et al.

Class IV-G and IV-S lupus nephritis in Chinese patients: A large cohort study from a single center. Lupus 2009; 18: 1073–1081.

18.

Wen

Hung

. Lupus vasculopathy combined with acute renal failure in lupus nephritis. Pediatr Nephrol 2003; 18(12): 1304–1307.

19.

Alaiya

Assad

Alkhafaji

et al.

Proteomic analysis of Class IV lupus nephritis. Nephrol Dial Transplant 2015; 30: 62–70.